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Dorsal axial formation during vertebrate embryogen-
esis exhibits robust resistance to perturbations in
patterning signals. However, how such stability is
supported at the molecular level remains largely
elusive. Here we show that Xenopus ONT1, an Olfac-
tomedin-class secreted protein, stabilizes axial for-
mation by restricting Chordin activity on the dorsal
side. When ONT1 function is attenuated, the embryo
becomes hyperdorsalized by a normally subeffective
dose of Chordin. ONT1 binds Chordin and BMP1/
Tolloid-class proteinases (B1TP) via distinct domains
and acts as a secreted scaffold that enhances B1TP-
mediated Chordin degradation by facilitating en-
zyme-substrate association. ONT1 is indispensable
for fine-tuning BMP signaling in the axial tissue, and
a similar role has been suggested for dorsally ex-
pressed BMPs such as ADMP. Simultaneous inhibi-
tion of ONT1 and dorsally expressed BMPs (ADMP
and BMP2) synergistically caused drastic dorsaliza-
tion. These results indicate that stable axial formation
depends on two compensatory regulatory pathways
involving ONT1/B1TP and dorsally expressed BMPs.
INTRODUCTION
In Xenopus, once the dorsal-ventral (DV) polarity of the embryo is
first determined by canonical Wnt signaling (reviewed in Heas-
man, 2006), an orchestrated regulation of BMP activity then
plays a central role in tissue patterning along the DV axis in the
Xenopus gastrula. The level of local BMP signaling provides
the ventral positional value in the embryonic field: high and low
BMP signaling, respectively, specify the ventral and dorsal iden-
tities. These BMP signaling levels are finely controlled along the
DV axis by positive (e.g., BMP ligands) and negative (e.g., BMP
antagonists such as Chordin and Noggin) factors, which are in-
teractively regulated at both the transcriptional and posttransla-
tional levels (Khokha et al., 2005; Lee et al., 2006; reviewed in De
Robertis and Kuroda, 2004).
However, although many regulatory molecules have been
identified, our understanding of their dynamic regulation as a net-854 Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc.work system is still limited. For example, although the organizer
factor/neural inducer Chordin inactivates the major ventralizing
factor BMP4 by binding to it in the extracellular space (Piccolo
et al., 1996), their functional and transcriptional relationships
are not simple. For instance, in the reverse direction, BMP4 sup-
presses Chordin expression (Reversade and De Robertis, 2005).
This mutual regulation, if working alone, would cause a problem
in the graded pattern formation of the embryo, because such
a double-inhibitory relationship functions as a positive-feedback
loop, which is unstable by nature and tends to cause catas-
trophic changes (Gardner et al., 2000). In this imaginary situation,
a small increase in Chordin would cause reduced BMP activity,
which in turn would desuppress (increase) Chordin expression.
As a result of such a chain reaction, the dorsal signal (Chordin)
would eventually predominate.
Contrary to such theoretical instability, the embryonic dorsal
axial pattern exhibits substantial resistance (or robustness) to
quantitative change in the level of patterning signals such as
Chordin (Reversade and De Robertis, 2005). In addition, classic
studies in experimental embryology provide several lines of
evidence for the robustness of dorsal axial patterning. First, the
Spemann organizer differentiates into the notochord (the original
fate of dorsal axial mesoderm) even after it is grafted to the ven-
tral-most part of the marginal zone (Spemann and Mangold,
1924), where the highest level of ventralizing signals is suppos-
edly present. In addition, normal development of the Xenopus
tadpole is observed even after a substantial ablation or addition
of organizer tissue at the early gastrula stage (Cooke, 1973,
1975). In the avian embryo, the dorsal axis is restored even after
total ablation of the node (Gallera and Nicolet, 1974; Joubin and
Stern, 1999). Another example is the bisection experiment in am-
phibian embryos. When an amphibian blastula is bisected into
dorsal and ventral halves, the dorsal half (which supposedly
lacks ventral information) develops into a small but normally
patterned embryo that contains both dorsal and ventral struc-
tures, whereas the ventral half develops only into pattern-less
ventral tissues called belly pieces (Reversade and De Robertis,
2005; Spemann, 1903). These findings indicate that a self-regu-
lating fail-safe system exists on the dorsal side of the amphibian
embryo.
Recent studies have implicated a BMP ligand, ADMP (anti-
dorsalizing morphogenetic protein), in the feedback regulation
of theChordin/BMPsystemon thedorsal side (DoschandNiehrs,
2000; Joubin and Stern, 1999; Lele et al., 2001;Moos et al., 1995;
Figure 1. Loss of Function of the Dorsally Expressed Protein ONT1
Causes Dorsalization of the Embryo
(A) Structure comparison of ONT1 with other Olfactomedin-class proteins. SP,
signal peptide; CC, coiled-coil domain; OLF, Olfactomedin domain.
(B–D) Whole-mount in situ hybridization of ONT1 expression at the early gas-
trula ([B]; sagittal section), midgastrula ([C]; sagittal section), and neurula ([D];
cross-section) stages. Brackets (B and C) showONT1 expression in the dorsal
axial tissues. The arrowhead in (B) indicates the dorsal lip. so, somite; not,
notochord.
(E and F) Radial injection of ONT1-MO (F) at the four-cell stage.
(G–N) Effects of ONT1-MO injection at the four-cell stage on DV markers ana-
lyzed in the gastrula. ONT1-MO (25 ng) caused expansion of the dorsal axial
markers Gsc ([G and K]; anterior view; stage 13), Chordin ([H and L]; dorsal
view; stage 13), and Shh ([I andM]; dorsal view; stage 13), whereas expression
of the ventral marker Szl was reduced ([J and N]; vegetal view; stage 12).
(O–R) Dorsalization induced by ONT1-MO (25 ng) injection at the four-cell
stage was rescued by coinjecting a small amount (4 pg) of MO-resistant
ONT1 RNA (ONTa(mut)). The expansion of dorsal markers Gsc (52%, n =
21), Chordin (54%, n = 13), and Shh (79%, n = 14) was reversed byONTa(mut)
(O–Q).Reversade and De Robertis, 2005). ADMP expression is found
in dorsal axial tissues in a manner similar to Chordin, and is
negatively regulated by BMP signals (Dosch and Niehrs, 2000;
Reversade and De Robertis, 2005). Conversely, the BMP ligand
ADMP contributes to the sum of ventralizing BMP signals, which
reduce the gene expression of the organizer factors (Moos et al.,
1995; Reversade and De Robertis, 2005). This feedback loop is
thought to contribute to the stabilization of DV patterning by
preventing the unlimited expansion of dorsal axial mesoderm.
However, ADMP by itself can only account for part of the feed-
back regulation, because the knockdown of ADMP by MO injec-
tion causes only moderate (noncatastrophic) dorsalization
(Reversade and De Robertis, 2005; also this paper).
In this study, we introduce XenopusONT1 as a keymolecule for
fine-tuningof theChordin/BMPsystem, andshow its essential role
for the posttranslational regulation of Chordin. ONT1 belongs to
a newly identified group of secreted proteins, called the Olfacto-
medin family (Zeng et al., 2005; see Figure S1A available online),
whose biological roles remain largely elusive.Olfactomedin-family
proteins have a coiled-coil domain (which is relatively diverse in its
amino acid sequence) in the amino-terminal half and a conserved
Olfactomedin domain in the carboxy-terminal half (Tsuda et al.,
2002). TwoOlfactomedin-related factorswerepreviously reported
toplaya regulatory role inneuraldevelopment.Noelin isexpressed
in the neural crest and prolongs the generation period of neural
crest production (Barembaum et al., 2000). Tiarin is expressed in
the nonneural ectoderm adjacent to the anterior neural plate and
induces dorsalization of the nervous tissues (Tsuda et al., 2002).
We recently isolatedachickOlfactomedin-family factor,ONT1,
which is distantly related to Noelin and Tiarin (Sakuragi et al.,
2006). Chick ONT1 is expressed in the axial and paraxial meso-
derm during early chick embryogenesis (Sakuragi et al., 2006).
To explore the possible roles of the Olfactomedin family in axial
patterning, we isolated a homolog in Xenopus (GenBank,
EMBL, DDBJ accession number AB440138; see Supplemental
Experimental Procedures), an animal model that allows detailed
molecular analysis of DVpatterning (Heasman, 2006;DeRobertis
and Kuroda, 2004). Here we demonstrate that ONT1 is a unique
pro-BMP factor that acts as a secreted scaffold for theB1TP-me-
diated degradation of Chordin. We show that ONT1 functions as
a key player in the dynamic control of Chordin protein levels.
Finally, we propose that ONT1, together with dorsally expressed
BMPs, plays an indispensable role in Chordin activity regulation
and ensures stable DV patterning in the embryo.
RESULTS
Xenopus ONT1 Is an Olfactomedin-Family Secreted
Factor Expressed on the Dorsal Side of the Embryo
Xenopus ONT1 encodes a secreted protein (392 amino acids
long) that contains a coiled-coil domain and anOlfactomedin do-
main (Figure 1A; these domains have 72% and 75% amino acid
(R) The reduction of Szl (70%, n = 20) was rescued by ONTa(mut).
(S and T) ONT1-MO was injected specifically into two dorsal (S) or ventral (T)
blastomeres at the four-cell stage. Gsc expression is shown in anterior view.
Insets show the expression of coinjected GFP in dorsal (S) and ventral (T) blas-
tomere progenies in the corresponding embryos.Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc. 855
identity, respectively, to those in the chick homolog). The Olfac-
tomedin domain of ONT1 shows moderate homology with those
of Noelin and Tiarin, whereas the coiled-coil domain is less con-
served. Recombinant ONT1 protein was efficiently secreted into
the culture medium by HEK293T cells overexpressing it and also
by dissociated cells of ONT1-injected Xenopus embryos
(Figure S1B; most secreted ONT1 appeared as a dimer; lanes
4 and 8).
In whole-mount in situ hybridization analyses, ONT1 expres-
sion appeared at the late blastula stage with diffuse labeling in
the animal region (Figure S1C). At the early gastrula stage,
ONT1 was expressed in the deep dorsal mesoderm (not in the
superficial zone) whereas its diffuse expression in the animal
cap was fading (Figure 1B). The expression in the dorsal meso-
derm continued during the mid-to-late gastrula stages
(Figure 1C). During the late gastrula and neurula stages, ONT1
expression was observed in the axial and paraxial mesoderm
(Figures 1D, S1D, and S1E), including the head mesoderm, con-
sistent with ONT1 expression in early chick embryos (Sakuragi
et al., 2006).
Attenuation of ONT1 Function Causes Dorsalization
To elucidate the in vivo function of ONT1, we performed loss-of-
function experiments in Xenopus using ONT1-MO (see Figures
S2A–S2C for the design and specificity of this test). Injection of
ONT1-MO induced the typical signs of dorsalization such as
a larger head and short body with thick dorsal structures in the
late tailbud embryo (73%, n = 70; Figure 1F). During the mid-
to-late gastrula stages, ONT1-MO caused expansion of the dor-
sal axial marker Goosecoid (Gsc; 100%, n = 20; Figures 1G and
1K), whereas injection of the control MO with five-base
mismatches had no effect (n = 14; Figures S2F and S2G).
ONT1-MO injection also expanded the expression of the dorsal
axial markers Chordin (100%, n = 12; Figures 1H and 1L) and
Shh (93%, n = 14; Figures 1I and 1M) as well as the expression
of the anterior neural plate markers Xanf and Otx2 (90%, n =
20 and 95%, n = 20, respectively; Figures S2D and S2E and
not shown; in Xenopus, augmentation of early organizer activity
causes both dorsalization and anteriorization due to head orga-
nizer induction). In contrast, ONT1-MO reduced Sizzled (Szl;
a ventral marker) expression (83%, n = 18) on the ventral side
(Figures 1J and 1N). The ONT1-MO-induced dorsalization phe-
notypes (expansion of Gsc, Chd, and Shh, and suppression of
Szl) were reversed by coinjecting a small amount (4 pg) ofMO-re-
sistant ONT1 RNA (with silent mutations; Figures 1O–1R). The
expansion of dorsal gene expression (Gsc) was observed when
ONT1-MO was injected into the dorsal blastomeres of four-cell
embryos (88%, n = 17; Figure 1S), but not into the ventral ones
(n = 19; Figure 1T), indicating that dorsally expressed ONT1 is
required for proper axial patterning.
These findings suggest that ONT1 is required for regulating the
level of dorsalization in dorsal embryonic tissues.
ONT1 Binds to Chordin and BMP1/Tolloid-Class
Proteinases via Distinct Domains
In the zygotic control of DV patterning in the amphibian embryo,
local BMP activity plays a decisive role in creating positional in-
formation along the axis. To explore the possible role of ONT1 as856 Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc.a modulator of BMP signals, we next examined in vitro the phys-
ical interactions of epitope-tagged ONT1 protein (overexpressed
by HEK293T cells) with extracellular components of BMP signal-
ing: BMPs, BMP receptors (BMPRs; extracellular domains), and
BMPmodulators. In in vitro immunoprecipitation assays (Figures
2 and S3), we observed no substantial association between
ONT1 and BMP4, ADMP, BMPRs (Ia, Ib, II), Crossveinless2
(Cv2), Sizzled (Szl), Twisted gastrulation (Tsg), Follistatin, or Nog-
gin protein (Figures S3A–S3I). In addition, ONT1 did not show
physical interactions with Wnt or Nodal proteins (Figures S3J
and S3K), which can induce dorsalization in Xenopus, either.
In contrast, ONT1 protein was efficiently coimmunoprecipi-
tated with Chordin in vitro (Figure 2A, lane 5), and this interaction
was mediated by the CR2–4 region of Chordin (Figures S4A and
S4B). Interestingly, physical interactions of ONT1 were also ob-
served between ONT1 and the BMP1/Tolloid-class proteinases
(B1TP) BMP1 (Figure 2B, lane 5) and Xolloid-related (Xlr;
Figure 2C, lane 5), which are known to degrade Chordin protein
(Blitz et al., 2000; Piccolo et al., 1997). Importantly, the coimmu-
noprecipitation of ONT1with Chordin (Figure 2E, lane 3) or BMP1
(Figure 2F, lane 3) was also observed using the secreted fraction
from a dissociation culture of RNA-injected Xenopus embryonic
cells. Analyses using deletion mutants (Figure 2G) revealed that
the Olfactomedin domain of ONT1 (Figure 2A, lane 7), but not its
coiled-coil domain (Figure 2A, lane 6), bound to Chordin, indicat-
ing that ONT1 physically interacts with Chordin in a domain-spe-
cificmanner. In contrast, the coiled-coil domain of theONT1 pro-
tein interacted with the two B1TP proteins (Figures 2B and 2C,
lane 6). ONT1 also binds to the Chordin-BMP4 complex in vitro
(Figure S4C), and the association between ONT1 and Chordin
is not strongly affected by the addition of BMP4 and/or Tsg pro-
tein (at an equimolar dose to Chordin; Figure S4D).
These observations show that ONT1 binds to Chordin and
B1TP via distinct domains (Figure 2H).
Loss of ONT1 Function Impairs the Robustness of
Embryonic Patterning against Increased Chordin Levels
The physical association betweenChordin and its proteolytic en-
zymes raised the possibility that ONT1 plays a role in modulating
extracellular BMP signaling via Chordin. Interestingly, embryonic
DV patterning shows substantial resistance to quantitative
changes in Chordin protein. The blastocoele injection of re-
combinant Chordin protein in the Xenopus blastula causes min-
imal change in the axial pattern (Reversade and De Robertis,
2005). We examined whether the depletion of ONT1 would affect
this robust resistance of DV patterning to increased Chordin
(Figure 3A).
Consistent with the previous report, injected recombinant
Chordin protein (44 fmol/blastocoele; which is sufficient to re-
verse the strong ventralizing effect of 22 fmol BMP4; Figures
S5A and S5B) at stage 9 caused only weak dorsalization, if
any, at this dose: a marginal increase inGsc expression and little
change in the expression pattern of the anterior forebrain marker
Rx (compare Figures 3D and 3H with Figures 3B and 3F). In con-
trast, whenONT1-MOwas injected in advance, the Chordin pro-
tein injection caused a dramatic increase in Gsc expression
(96%, n = 26; Figure 3E) and a marked expansion of Rx expres-
sion (extending even to the ventral and posterior side; 96%,
n = 26; Figure 3I). Similar hyperdorsalization phenotypes in
ONT1-MO-injected embryos were observed when Chordin was
injected at stage 11 (Figures S5C–S5F). Coinjection of MO-resis-
tant ONT1 RNA (silent mutation) inhibited hyperdorsalization
caused by Chordin and ONT1-MO (no drastic Gsc expansion
in 87%, n = 15; Figure S5H). ONT1-MO injection experiments
into dorsal- or ventral-specific blastomeres showed that the
loss of ONT1 function on the dorsal side caused severe hyper-
sensitivity to injected Chordin protein (Figures S5I and S5K),
Figure 2. ONT1 Binds to Chordin and B1TP
via Distinct Domains
(A) HEK293T cell-produced Chordin, Flag-tagged
ONT1, ONT1 coiled-coil-domain (CC), and ONT1
Olfactomedin-domain (OLF) proteins were used
for immunoprecipitation with anti-Flag M2 affinity
gel. An immunoblot is shown with the anti-N/Chd
antibody.
(B and C) ONT1 binds to B1TP via its CC domain.
HEK293T cell-produced BMP1, Flag-tagged
ONT1, CC, and OLF proteins were used (B). The
interaction of Xlr and ONT1 was analyzed with an
anti-myc antibody (C).
(D) Loading control of Flag-tagged ONT1, CC, and
OLF proteins by Coomassie brilliant blue (CBB)
staining following the immunoprecipitation. Aster-
isk, a minor partial fragment of ONT1 (confirmed
by the Edman degradation method).
(E and F) Xenopus embryos given an injection of
Chordin mRNA (400 pg) and ONT1-Flag mRNA
(400 pg) (E), or BMP1 mRNA (500 pg) and ONT1-
Flag mRNA (300 pg) (F). RNA-injected embryos
were dissociated into CMFM (calcium/magne-
sium-free medium) at stage 10.5, and the condi-
tioned medium was harvested at stage 13.
(G) Schematic of ONT1 and ONT1-deletion con-
structs.
(H) ONT1 binds to BMP1 via the CC and to the
CR2–4 region of Chordin via the OLF.
whereas ventral injection sensitized the
embryo to only a minor extent (Figures
S5J and S5L).
These findings indicate that ONT1
function is indispensable for the robust-
ness of dorsal patterning with respect to
the Chordin-regulated mechanism.
ONT1 Promotes BMP1-Mediated
Chordin Degradation as a Secreted
Scaffold
Because the in vivo expression of ONT1
overlaps with the expression of Chordin
and the B1TP genes (BMP1 and Xlr;
Figure S6), we became interested in the
possibility that ONT1 might promote
BMP1-mediated Chordin degradation by
acting as a secreted scaffold (or an adap-
tor protein; reviewed in Burack and Shaw,
2000; Ferrell, 2000) of the proteinase and its substrate, Chordin.
In the in vivo experiment, we coinjected Chordin RNA with
a moderate dose of BMP1 RNA that is sufficient for only a partial
reduction of the Chordin protein in the extracellular fraction (Fig-
ures 4A and 4B, lanes 2 and 3). If the scaffold model is correct,
the appropriate doses of ONT1 should promote Chordin degra-
dation. In contrast, excessively high doses of ONT1 should
inhibit degradation because the ONT1 proteins would bind indi-
vidually to each protein, leading to the segregation of ChordinCell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc. 857
and BMP1 (Figure 4D). Consistent with these predictions, the
coinjection of ONT1 (up to 100 pg/embryo) reduced the Chordin
level in a dose-dependent manner (Figure 4B, lanes 3–7; Fig-
ure 4C), whereas the injection of higher doses of ONT1 dose-
dependently increased undigested Chordin, resulting in Chordin
levels comparable to those of the BMP1-uninjected control
(Figure 4B, lanes 2 and 8–10; Figure 4C).
Similar biphasic effects (dose-dependent facilitation and inhi-
bition) of ONT1 on B1TP-mediated Chordin degradation were
also observed in the in vitro assay using HEK293T-produced
proteins (Figure 4E; Xlr was used in this assay by the reasoning
described in Experimental Procedures). Importantly, when
a low-molecular-weight peptide ligand for B1TP was used (Lee
et al., 2006), the addition of ONT1 protein did not affect the en-
zymatic activity (Figure 4F), indicating that the enhancement of
cleavage is a substrate- (Chordin) specific phenomenon.
Another prediction from this scaffold model is that a higher
dose of the enzyme should shift the window for the optimal
ONT1 doses. To test this, we titrated ONT1 in the in vitro diges-
tion assay of Chordin using three different doses of Xlr
(Figure 4G; the amounts of the digested amino-terminal fragment
were quantified; Figure S7A). In the presence of higher doses of
Xlr (green and red), facilitation of Chordin digestion was
observed even at higher concentrations of ONT1 (Figure 4G,
lanes 5 and 6), at which the inhibition of proteolysis was seen
when a low dose of Xlr (blue) was used (Figure 4H illustrates
the ratios to the zero-ONT1 control shown in lane 2), showing
that the optimal range of ONT1 was shifted (or widened) to the
higher direction. Consistent with the binding data (Figure S4D),
the presence of BMP4 and/or Tsg protein does not substantially
affect the enhancement of Xlr-mediated Chordin degradation by
ONT1 in vitro (Figure S4E).
To obtain direct molecular evidence for the scaffold model, we
attempted to isolate and analyze the enzyme-substrate complex
Figure 3. ONT1 Is Required for Robust
Resistance to Increased Chordin in DV
Patterning of the Early Xenopus Embryo
(A) Recombinant Chordin protein (44 fmol/blasto-
coele) was injected into the blastocoele at stage
9. Effects on DV patterning were examined at
stage 13.
(B–I) Whole-mount in situ hybridization with the
Gsc probe ([B–E]; anterior-dorsal oblique view)
and the mixed probes ([F–I]; Rx, Krox20, and
MyoD; anterior-dorsal oblique view). Embryos
were given an injection of Chordin protein ([D, E,
H, and I]; Chd-prot) or control BSA (B, C, F, and
G) as shown in (A).
(C, E, G, and I) Embryos were injected with
ONT-MO (25 ng) at the four-cell stage.
(so-called Michaelis complex) of Chordin
and B1TP, but it was not detectable in
western blots (data not shown), presum-
ably because of the low abundance of
the transient intermediate complex. To
stabilize the enzyme-substrate complex
by preventing its hydrolysis, we next
used a dominant-negative BMP1 (dnBMP1; mutated BMP1
according to tolloidmutation; following Piccolo et al., 1997). Epi-
tope-tagged ONT1, Chordin, and dnBMP1 proteins were sepa-
rately overproduced in HEK293T cells and purified with Ni-NTA
beads from conditioned medium. Immunoprecipitation assays
of dnBMP1 (using a Flag antibody) showed that the association
of dnBMP1 and Chordin substantially increased when a small
amount of ONT1 was present (compare lanes 3 and 4 in Figures
4I and 4J). In contrast, as predicted from the model in Figure 4D,
excessive amounts of ONT1 interfered with the binding of
dnBMP1 and Chordin (Figures 4I and 4J, lanes 8 and 9). These
observations demonstrate that, at an appropriate dose, ONT1
indeed functions as a binding scaffold that promotes enzyme-
(B1TP) substrate (Chordin) association.
We further confirmed the secreted scaffold model in the in vivo
context. First, if the model in Figure 4D is correct, a simultaneous
partial reduction of ONT1 and B1TP proteins should synergisti-
cally reduce Chordin degradation and thereby promote dorsali-
zation in the embryo. We therefore performed coinjection exper-
iments of BMP1-MO and ONT1-MO. When each MO was
injected separately at a low dose (half of the effective dose), no
substantial expansion of Gsc expression was seen (Figures
S7C and S7D). However, when the two MOs were combined,
they strongly increased Gsc expression in the injected embryo
(92%, n = 12; Figure S7E) to a level greater than that seen with
ONT1-MO or BMP1-MO alone at higher doses, indicating that
ONT1 and B1TP cooperatively regulate Chordin levels.
Second, this scaffold model predicts that the presence of ex-
cessive ONT1 (which causes the sequestration of Chordin and
B1TP) should result in dorsalization, instead of ventralization,
due to the reduction of B1TP-mediated Chordin degradation.
Indeed, overexpression ofONT1 caused dorsalization in the em-
bryo instead of ventralization (100%, n = 28; Figure 5B). ONT1
overexpression increased the dorsal marker Gsc (77%, n = 30;858 Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc.
Figure 4. ONT1 Promotes BMP1-Mediated
Chordin Degradation as a Catalytic Scaffold
(A) Embryos were given an injection of ChordinmRNA
(100 pg), BMP1 mRNA (100 pg), or ONT1-Flag mRNA
(12.5–600 pg). At stage 12, the embryos were dissoci-
ated in cold CMFM containing 5 mM EDTA and pro-
teinase inhibitors.
(B) The secreted Chordin proteins (upper), secreted
ONT1 (middle), and Chordin proteins in the lysate (bot-
tom) were detected by immunoblot.
(C) The relative secreted Chordin protein level of (B)
was quantified. The level of lane 3 was defined as 1
and the other levels are expressed relative to this.
(D) A scaffold model.
(E) HEK293T-produced Chordin-V5/His (equivalent to
40 ml of the conditioned medium), Xlr-Flag (equivalent
to 12 ml of the conditioned medium), and Flag-ONT1/
His were mixed and incubated at 25C for 5 hr. The
amount of ONT1 protein in lane 7 is equivalent to
that purified from 3.8ml of conditionedmedium. Lanes
3–6 are 4-fold serial dilutions of the lane 7 sample.
(F) Purified Flag-ONT1/His and Xlr-Flag were mixed
under the same conditions as in (E), and a synthetic
fluorogenic heptapeptide was added instead of Chor-
din-V5/His. The relative proteolytic activity of Xlr on the
heptapeptide is presented as a histogram.
(G and H) The optimal ONT1 doses depend on the
amounts of Xlr protein. The purified Chordin-V5/His,
Xlr-Flag, and Flag-ONT1/His proteins were mixed
and incubated at 25C for 6 hr. The cleaved N-terminal
fragment of Chordin was detected by immunoblotting
with the anti-N/Chd antibody (Figure S7A). The
cleaved Chordin level in lane 1 (Xlr-Flag and Flag-
ONT1/His at 0 nM) was defined as 1 in (G), and lane
2 (Flag-ONT1/His at 0 nM) was defined as 1 in (H).
(I) Purified Chordin-V5/His (1.5 nM), dnBMP1-Flag/His
(1.5 nM), and ONT1-V5/His (0–12 nM) were mixed
together and immunoprecipitated with anti-Flag M2
affinity gel. Chordin-V5/His and ONT1-V5/His were
detected by immunoblotting with an anti-V5 antibody
(upper row) and dnBMP1-Flag/His was detected
with an anti-Flag antibody (bottom row).
(J) The relative levels of Chordin protein (as in [I]) are
shown as a graph. The Chordin protein level in lane 3
(ONT1-V5/His at 0 nM) was defined as 1.Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc. 859
Figure 5D) and suppressed the ventral marker Szl (100%, n = 23;
Figure 5F). Consistent with this idea, in the ONT1-MO injection
experiments, coinjection of a small amount of ONT1 RNA (4 pg
is optimal) rescued the expression of Gsc and Szl, whereas
Figure 5. Excessive Doses of ONT1 Cause Dorsalization in the
Embryo
(A and B) The dorsalized phenotype was observed following the injection of
ONT1 mRNA (200 pg; [B]).
(C–F)Microinjection ofONT1mRNA (200 pg) increased the dorsal markersGsc
([C and D]; anterior view) and Chordin (not shown) and suppressed the ventral
marker Szl ([E and F]; vegetal view).
(G) Embryos were classified by morphological inspection of (H)–(L).
(H–L) Stage 23 embryos received injections of BMP1mRNA (200 pg) or ONT1
mRNA (400 pg) into the two dorsal blastomeres at the four-cell stage. Overex-
pression ofONT1 reversed the ventralization induced byBMP1 (I and J) but not
a constitutively active form of BMPR (CA/BMPR; 6.25 pg; [K and L]).
(M–O) The dorsalizing effect of ONT1 overexpression requires Chordin. In situ
hybridization for the indicated markers in a control embryo (M) or in embryos
given an injection of Chordin-MO (4 ng each; N) or ONT1 mRNA (200 pg) +
Chordin-MO (4 ng each) (O).860 Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc.high doses of ONT1 injection expanded Gsc expression and
suppressed Szl expression (Figures S2H–S2Q).
Overexpression of ONT1 reversed the ventralization pheno-
type induced by BMP1 (Figures 5G–5J; Figure 5J shows an ex-
ample of the normalized embryos counted in Figure 5G), but
not the ventralization caused by a constitutively active form of
BMPR (Figures 5K and 5L), suggesting that ONT1 acts some-
where between BMP1 and BMP receptors (consistent with the
BMP1-Chordin system). In addition, ONT1 overexpression did
not substantially reverse the ventralization caused by Chordin-
MO (n = 20; Figures 5M–5O), suggesting that the dorsalizing
effect of ONT1 overexpression requires Chordin. These findings
demonstrate that the overexpression phenotypes of ONT1 are
also related to the B1TP-Chordin system. ONT1 overexpression
did not interfere with eitherWnt8-induced axis duplication in vivo
or Xnr1-inducedmesodermalization in the animal cap assay (Fig-
ures S8A–S8C).
Taken together, these observations support the idea that
ONT1 acts as a secreted scaffold that promotes Chordin degra-
dation by B1TP.
ONT1 and ADMP Function Together in a Dual-Safety
Stabilizing System for Axial Patterning
We next examined the regulation of ONT1 expression by BMP
signaling and compared it with the transcriptional control of rel-
evant genes (Figure 6A). ONT1 expression was substantially
increased (3.3-fold) by the injection of BMPs-MO (mixed MOs
for four BMPs; Reversade and De Robertis, 2005) and sup-
pressed by BMP4 in the late gastrula embryo (Figure 6A, lanes
1–3). These results demonstrate that the expression of ONT1
at this stage is negatively regulated by ventralizing (BMP) signals,
as is the expression ofChordin (lanes 4–6) and ADMP (lanes 7–9;
its expression is extremely sensitive to BMP attenuation, as
reported by Reversade and De Robertis, 2005). The expression
of the ventral gene Szl was regulated in the opposite manner
(lanes 16–18). In contrast, the level of BMP1 expression ap-
peared less dependent on BMP signaling; it showed relatively
little change upon reduction in BMP signals (lanes 13 and 14)
and was only partially suppressed by BMP4 (lane 15).
The dorsally expressed BMP ligandADMPhas been implicated
in the feedback control of the Chordin/BMPsystem for dorsal pat-
terningasabalancermolecule (ReversadeandDeRobertis, 2005).
Importantly, the two pro-BMP factors ADMP and ONT1 evidently
differ in their modes of action. ADMP works by binding to BMP
receptorswhereasONT1acts viaChordindegradation. Therefore,
we next performed a double-knockdown study to examine the
possible functional relationship between ONT1 and ADMP. The
single injection ofONT1-MO (12.5 ng) orADMP-MO (3 ng) caused
a relatively moderate increase in Gsc expression (Figures 6C and
6D) in the gastrula (the increasewas3-fold for eachMObyquan-
titative RT-PCR; Figure 6F). In contrast, coinjection of ONT1-MO
and ADMP-MO led to a very strong induction of Gsc (100%, n =
15; Figures 6E and 6F;20-fold by quantitative RT-PCR), indicat-
ing that the two MOs worked together in a synergistic (nonlinear)
fashion. Consistent with this idea, the embryos injected with
bothMOsexhibitedaseveredorsalizationandanteriorizationphe-
notype: enormous expansion of the head (see the expansion ofRx
expression and the caudal shift of Krox20 expression; 100%,
n = 18; Figure 6H) and marked enlargement of the dorsal axial
marker Shh (100%, n = 19; Figure 6J). (The modest phenotypes
in single MO injections may be partly explained by the fact that
ONT1-MO increased ADMP expression whereas ADMP-MO
induced ONT1 expression; Figure S9A.) Coinjection of Chordin-
MO reversed the hyperdorsalization phenotypes induced by the
double knockdown of ONT1 and ADMP (reversion inGsc expres-
sion, 100%, n = 12 and in the mixed probe pattern, 100%, n = 14;
compare Figures 6K and 6L with Figures 6E and 6H). These find-
ings support the idea that ONT1 and ADMP both participate in
the Chordin/BMP regulatory network, presumably in two parallel
compensatory pathways.
Given that ONT1 acts through B1TP activity, B1TP-MO should
mimicONT1-MOwith respect to thedouble-knockdownphenotype
with ADMP. Indeed, whereas the knockdown of two B1TPs (BMP1
and Xlr) had only amoderate effect (no strong expansion ofGsc ex-
pression, n = 12; compare Figures 6B and 6M), the simultaneous
knockdownofB1TPsandADMPcooperatively causeda strongex-
pansionofGscexpression in the gastrula (100%, n=12; Figure 6N),
Figure 6. Double Knockdown of ONT1 and
ADMP Induces a Severe Dorsalization of
the Embryo
(A) Quantitative RT-PCR analysis. A mixture of
BMP2-MO (8 ng), BMP4-MO (4 ng), BMP7-MO
(4 ng), and ADMP-MO (8 ng) (BMPs-MO; Rever-
sade and De Robertis, 2005) or BMP4 mRNA
(12.5 pg) was injected radially at the four-cell
stage, and embryos were harvested at stage 13.
The level of the control was defined as 1. ODC,
ornithine decarboxylase.
(B–E) The expression of Gsc (anterior view) was
strongly expanded at stage 13 in the ONT1-MO
(12.5 ng) and ADMP-MO (3 ng) coinjected embryo.
(F) Quantitative RT-PCR analysis of Gsc expres-
sion levels under the same conditions as in
(B)–(E). ONT1-MO and ADMP-MO synergistically
upregulated Gsc expression. The level of the con-
trol was defined as 1.
(G–J) ONT1-MO (12.5 ng) and ADMP-MO (3 ng)
coinjection caused a strong expansion of the ante-
rior neural marker Rx (G and H) and dorsal axial
marker Shh (I and J) at stage 13. Dorsal views.
(K and L) Coinjection of Chordin-MO reversed the
hyperdorsalization induced by the double knock-
down of ONT1 and ADMP. The strong expansion
of Gsc (anterior view) or Rx (dorsal view) induced
by the double knockdown of ONT1-MO (12.5 ng)
and ADMP-MO (3 ng) was reversed by Chordin-
MO (4 ng each) at stage 13.
(M and N) Double knockdown of B1TP (BMP1 and
Xlr) and ADMP caused a strong expansion of Gsc
expression (anterior view) at stage 13. Embryos
were given an injection of BMP1-MO (6 ng),
Xlr-MO (6 ng), and ADMP-MO (3 ng).
as was seenwith the double knockdown of
ONT1 and ADMP (Figure 6E). Thus, the si-
multaneous block of ADMP and either
ONT1 or B1TP resulted in a marked shift
toward hyperdorsalization.
Together, these results indicate that the regulative develop-
ment of dorsal axial tissues requires the unique secreted scaffold
ONT1, which contributes to the robust stability of axial patterning
in concert with B1TP and ADMP on the dorsal side.
Interestingly, we also observed that the ventrally expressed
B1TP antagonist Szl competed with ONT1 for B1TP binding.
This mechanism may further restrict ONT1 function along the
DV axis (Figure S9B, lanes 3 and 4; Lee et al., 2006; Muraoka
et al., 2006; Salic et al., 1997).
Redundant Roles of BMP2 and ADMP in Dual-Safety
Regulation
Although the expansion of dorsal markers such as Gsc by
ONT1-MO and ADMP-MO was thus drastic, the expansion of
axial Shh+ tissues (the dorsal-most tissues) was still largely con-
fined to the proximity of the dorsal midline region (Figure 6J).
Therefore, we presumed that, in addition to ADMP, some other
BMP factors might be involved in the robust stability of dorsal
axial patterning.Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc. 861
A strong candidate for this role is BMP2, whose expression,
like ADMP expression, was induced by BMPs-MO and sup-
pressed by BMP4 injection in the late gastrula embryo
(Figure 6A, lanes 10–12). This regulation of BMP2 expression
may reflect its in vivo expression in the anterior-most region of
the embryo (anterior mesendoderm derived from the dorsal lip)
during the gastrula stages (stage 11 and onward: Figures
S10C–S10F and S10M; compare with ADMP expression in Fig-
ures S10G–S10L). Upregulation of BMP2 expression by BMPs-
MO injection was also observed by in situ hybridization at stage
11, whereas BMP4 injection suppressed it (Figures S10M–
S10O). More importantly, the double knockdown by ONT1 and
ADMP caused strong induction of BMP2 expression (83%, n =
18; Figures 7A and 7B; stage 11.5). These observations raised
the possibility that BMP2 participates in feedback regulation in
a partially overlapping fashion with the function of ADMP.
Consistent with this idea, the double knockdown of ADMP and
BMP2 induced a substantial upregulation of Gsc and Shh ex-
pression (100%, n = 12 and 100%, n = 11, respectively; Figures
Figure 7. Triple Knockdown of ONT1, ADMP, and BMP2 Results in
a Dramatic Shift toward Dorsalization
(A and B) BMP2 expression (dorsal view) was strongly expanded at stage 11.5
in an embryo coinjected with ONT1-MO (12.5 ng) and ADMP-MO (3 ng).
(C–H) Triple knockdown of ONT1, ADMP, and BMP2 caused a dramatic dors-
alization of the embryo. Embryos were given microinjections of ADMP-MO
(3 ng), BMP2-MO (8 ng), and ONT1-MO (8 ng). Whole-mount in situ hybridiza-
tion of Gsc ([C, E, and G]; anterior view) and Shh ([D, F, and H]; dorsal view)
expression at stage 13.862 Cell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc.7E and 7F), suggesting that BMP2 and ADMP have partially
redundant roles. However, as was also seen with the double-
knockdown phenotype of ADMP and ONT1, the expansion of
the dorsal axial markerShhwas still limited to the neighboring re-
gions of the normal expression sites (Figure 7F). In contrast, the
triple knockdown of ADMP, BMP2, and ONT1 caused a severe
expansion of Gsc and Shh expression (100%, n = 14 each; Fig-
ures 7G and 7H). These findings indicate that the stabilization
mechanism of axial development nearly collapsed on the dorsal
side in this triple knockdown.
Collectively, the experimental results in this study clearly dem-
onstrate thepresenceofadual-safetymechanism for stabledorsal
axial patterning that involves two parallel mechanisms involving
ONT1/B1TP pathway and ADMP/BMP2 loop (Figure S10P).
DISCUSSION
ONT1 as a Secreted Scaffold for Facilitated Chordin
Degradation
This report introduces ONT1 as a novel type of pro-BMP regula-
tor that acts in the extracellular signaling network, that is, as
a secreted scaffold for Chordin degradation. An important
unique property of ONT1 is that it is a secreted scaffold that in-
teracts with extracellular enzymes, unlike the previously reported
scaffolds, which function with intracellular proteins (e.g., ki-
nases; Whitmarsh et al., 1998). This study shows that ONT1 pro-
motes Chordin-BMP1 association in vitro (Figures 4I and 4J).
Whether ONT1 may also act by increasing enzymatic turnover
(i.e., as a catalytic scaffold) is a challenging, unresolved question
that requires extensive enzymological analyses.
Besides its quantitative role in promoting Chordin degrada-
tion, ONT1 may also have a qualitative role as a scaffold that
involves substrate specificity regarding its mode of action.
Several other molecules including collagen have also been
suggested as candidate in vivo substrates of B1TP (reviewed
in Ge and Greenspan, 2006). It is therefore possible that the sub-
strate-selective nature of ONT1’s action is important for specifi-
cally promoting Chordin degradation by B1TP in vivo, where
these competitive substrates are present.
We have so far been unable to obtain an accurate quantifica-
tion of endogenous ONT1 protein by a strong specific antibody.
In our preliminary experiment, we injected a small amount of
ONT1 RNA (0.125–8 pg at the four-cell stage; note that 4 pg is
optimal for the rescue experiment in Figure 1) to see whether
a small increase in ONT1 level would slightly ventralize (instead
of dorsalize) the embryo by enhancing Chordin degradation.
However, no obvious ventralization (increase in Szl) was seen
with an ONT1 injection at any dose (Figure S2R); in fact, the
expression of the ventral marker decreased. One possible inter-
pretation is that the in vivo level of endogenous ONT1 is already
close to the optimal concentration and that its further increase
results in B1TP inhibition.
Reinforcement of Dorsal Axial Pattern Stability by ONT1
In embryoswith decreasedONT1 function, the injection of a sub-
effective dose of Chordin protein led to substantial instability in
dorsal axial specification and caused hyperdorsalization (Fig-
ure 3). The attenuation of ONT1 function also strongly sensitized
the response of the embryo to decreased ADMP and BMP2 sig-
nals (Figures 6 and 7). In contrast, ONT1 does not bind to Noggin
(Figure S3I), and ONT1-MO injection showed relatively little
synergism with Noggin injection (Figures S5M–S5P).
The presence of both dynamic flexibility and strong robust-
ness in the same integrated system is a fundamental character-
istic of living organisms. Multiple strategies can theoretically
work together to reinforce the stability (or robustness) of a system
against the substantial perturbation of critical parameters. These
include feedback regulation, redundancy, and compartmentali-
zation (Kitano, 2007; Niehrs andMeinhardt, 2002). Compartmen-
talization of the regulatory system into multiple modules limits
the effects of a break in stability to within the compartment, pre-
venting it from influencing the entire system.
BMP-depletion experiments (Figure 6A) suggest that the level
of ONT1 expression could be regulated in a negative feedback
loop at least during late gastrulation. Double-knockdown exper-
iments showed that ONT1 and ADMP function in a redundant
manner (Figure 6). With respect to compartmentalization,
ONT1 and ADMP do not overlap in their modes of action (an
enzyme-substrate scaffold and a BMP ligand) and, therefore,
can function as regulators at different levels (i.e., as distinct func-
tional modules). Moreover, the two modules may also function in
a mutually compensatory fashion via transcriptional control
(Figure S9A). This coupling of two functional modules further
reinforces the stability of the system against perturbation in
a fail-safe manner (Horikawa et al., 2006; Figure S10P).
Spatial and Temporal Regulation by ONT1
and ADMP/BMP2 In Vivo
The spatial and temporal expression patterns of other regulators
in the Chordin/BMP system are also dynamic. In normal em-
bryos, ADMP expression is mostly limited to the axial tissue,
where Chordin expression is highest (Figures S10G–S10L).
In contrast, ONT1 expression is not limited to the axial meso-
derm even at the late gastrula stage, and it is also expressed in
the paraxial mesoderm (Figures 1D, S1D, and S1E; data not
shown). Thus, ONT1 may also promote Chordin degradation at
a distance from the site of Chordin expression, whereas ADMP
normally forms a negative feedback loop close to the dorsal mid-
line. Upon the substantial perturbation of DV patterning signals,
however, both ONT1 and ADMP are likely to function beyond
their normal ranges (Figures 6 and 7) and together equilibrate
local BMP signaling.
Part of ADMP’s role appears to be compensated for by
another BMP ligand, BMP2, whose expression is regulated by
dorsal influences (Figures 7 and S10). The dynamic BMP2
expression in the anterior region may contribute to the stabiliza-
tion of DV positional values in rostrally migrating dorsal cells,
including head organizer cells, during transitional phases. Inter-
estingly, the anterior expression of Xlr largely overlaps with that
of BMP2 during midgastrulation (Figure S6E).
With respect to the timing of action for DV pattern stability,
the classic embryological study (organizer deletion and addi-
tion) has shown the presence of strong robustness in axial
specification even after the onset of gastrulation in Xenopus
(Cooke, 1973, 1975), although a previous study using Smad-
GR suggested that BMP signaling has stronger effects on DVpatterning at the pregastrula stage than after it (Marom et al.,
2005). Interestingly, blastocoele injection of Chordin protein at
stage 11 also caused hyperdorsalization when combined with
ONT1-MO injection (Figures S5C–S5F), suggesting that the
dynamic Chordin/BMP system (including ONT1-mediated ro-
bustness) controls dorsal axial patterning during the gastrula
stages.
Possible Roles of ONT1 in Nonaxial DV Patterning
Thus, the role of ONT1 is consistent with the classic bisection
experiment showing that the main regulative mechanism of
dorsal axis formation exists on the dorsal side, rather than
the ventral side, which forms only a belly piece when grown
alone. On the ventral side, a number of BMP4 synexpression
group genes including Szl (Niehrs and Pollet, 1999) seem to
contribute to the stabilization of ventral identity via mutual reg-
ulation: this ventral system, which forms its own self-regulatory
compartment, has also been referred to as the ‘‘ventral signal-
ing center’’ (Reversade and De Robertis, 2005; Plouhinec and
De Robertis, 2007).
A working hypothesis for the possible integration of dorsal and
ventral factors in the Chordin/BMP system is illustrated in
Figure S11. Based on this and previous studies, we deduce
that the mechanism of the entire DV patterning process involves
two related but distinct regulations of stability: ‘‘robustly stable
axial formation and maintenance’’ in the axial (organizer) region,
and ‘‘dynamic and flexible pattern generation and maintenance’’
in the nonaxial (nonorganizer) marginal zone.
EXPERIMENTAL PROCEDURES
Embryonic Manipulation, Microinjection, and RNA Analysis
Embryos received mRNA or MO injections four times radially at the four-cell
stage unless mentioned otherwise. Antisense MOs for Xenopus laevis ONT1,
BMP1, and Xlr were obtained from Gene Tools. Blastocoele injection was
performed as described (Pera et al., 2003). Blastula embryos were injected
into the blastocoele cavity with 40 nl of recombinant mouse Chordin (44
fmol; R&D Systems), human BMP4 (22 fmol; R&D), and mouse Noggin/Fc
(22 fmol) in 0.13 Barth medium containing 0.1% BSA. Quantitative RT-
PCR was performed on the 7500 Fast Real-Time PCR system (Applied
Biosystems) using the Power SYBR Green PCR Master Mix (Applied Biosys-
tems). Detailed information is available in Supplemental Experimental Proce-
dures.
Immunoprecipitation Assays
For coprecipitation assays using conditioned medium of HEK293T cells, cells
were transfected separately with each plasmid expression vector using the
FuGENE6 transfection reagent. After 24 hr, the cells were washed twice with
Hank’s buffer and cultured in serum-free OptiMEMI (Invitrogen) for another
48 hr. Conditioned media-containing proteins were immunoprecipitated using
anti-Flag M2 affinity gel (Sigma) in the presence of 0.1% NP40 and 0.1% BSA.
For coprecipitation assays using proteins secreted by Xenopus embryonic
cells, mRNA-injected embryos were dissociated using CMFM (calcium/mag-
nesium-free medium) containing 0.1% BSA, and allowed to secrete proteins
into the medium during stages 10.5–13 (equivalent). Conditioned medium
was subjected to the coprecipitation assay after the concentrations of CaCl2
(to final 0.9 mM), MgCl2 (to final 0.33 mM), and NP40 (to final 0.1%) were ad-
justed. A coprecipitation assay was done using purified proteins or recombi-
nant proteins mixed in Hank’s wash buffer (Hank’s buffer containing 20 mM
HEPES [pH 7.1], 0.1% NP40, and 1 mM ZnCl2) containing 0.1% BSA. The pro-
duction of Chordin antibodies and information on other recombinant proteinsCell 134, 854–865, September 5, 2008 ª2008 Elsevier Inc. 863
and immunoprecipitation assays are described in Supplemental Experimental
Procedures.
In Vivo and In Vitro Chordin Cleavage Assays
For in vivo cleavage assays, RNA-injected embryos were collected at stage 12
and dissociated in ice-cold CMFM containing 0.1% BSA, 5 mM EDTA, and
protease inhibitor cocktail (EDTA-free; Nacalai Tesque). After centrifugation,
the supernatant received NP40 to a final 0.5% concentration and collected
as the ‘‘secreted’’ fraction. The precipitate was lysed at 4C in TNE buffer
(50 mM Tris-HCl [pH 7.8], 1%NP40, 20 mMEDTA, and 150 mMNaCl) and col-
lected as the ‘‘lysate’’ fraction.
For in vitro cleavage assays, full-length ONT1 protein was purified from me-
dium conditioned by HEK293T cells transfected with pcDNA6-Flag-ONT1/His
(the Flag tag was inserted just after the signal sequence, and the 63 His tag
was inserted before the stop codon). Conditioned medium was prepared as
described above, and Flag-ONT1/His protein was purified using Ni-NTA aga-
rose beads (QIAGEN). To strictly avoid contamination, the eluted fractions
were further purified with anti-Flag M2 affinity gel according to the manufac-
turer’s instructions. Chordin-V5/His and Xlr-Flag protein were also prepared
from medium conditioned by HEK293T cells transfected with their expression
vectors. For in vitro digestion, purified Flag-ONT1/His, Chordin-V5/His, or Xlr-
Flag was incubated in buffer (10 mM HEPES [pH 7.6], 150 mM NaCl, 2.5 mM
CaCl2, 1mMMgCl2, and 1 mMZnCl2; Piccolo et al., 1997) containing 0.2 mg/ml
BSA for 5 hr at 25C. Detailed information is available in Supplemental Exper-
imental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include 11 figures and Supplemental Experimental Proce-
dures and can be found with this article online at http://www.cell.com/cgi/
content/full/134/5/854/DC1/.
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